VAERS reports by lot

GSK Varicella/Shingles lot L7F7E: VAERS reports

88 VAERS reports list lot L7F7E as a GSK Varicella/Shingles vaccine, received between 2018-06-04 and 2023-07-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
88
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)10031%
Injection-site / Local reaction6119%
Neurological4414%
Dermatological (non-injection-site)3912%
Gastrointestinal227%
Musculoskeletal227%
Allergic / Anaphylactic206%
Cardiac / Cardiovascular72%
Respiratory41%
Psychiatric / Neuropsychiatric31%
Thrombotic / Hematological21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas20
Pennsylvania7
Michigan6
Minnesota5
Wisconsin4
Iowa4
California4
New York4
Connecticut4
Missouri2
Illinois2
Oklahoma2

Reports by month received

2018-0634
2018-0733
2018-086
2018-093
2018-106
2018-113
2018-122
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.